Month: June 2022

KANSAS CITY, Kan., June 17, 2022 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and Chief Executive Officer, Shane J. Schaffer, PharmD, will present a company overview at the Diamond Equity Research 2022 Virtual Emerging Growth Invitational on Thursday, June 23, 2022 at 1:40 PM EST. Following the presentation, Dr. Schaffer will take questions from participants. Investors can register for the conference at: Diamond Equity – Conference Registration.   A live webcast of the presentation may be accessed at: Diamond Equity – Cingulate Live Presentation. A replay will be available on the investor...

LITTLE ROCK, Ark., June 17, 2022 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and agencies, is set to attend Cannes Lions: The International Festival of Creativity, which will return to Cannes, France for the first time since 2019, on June 23. Rich Howe, Chairman and Chief Executive Officer of Inuvo, is issuing a challenge to their ad-tech competitors to mark the occasion. “We welcome Google’s plan to eliminate cookies next year,” said Inuvo Board Member Jon Bond. “Tracking and building persistent user profiles to use in real-time ad buying is already difficult due to increasingly unstable cookies, the accelerated adoption of VPN, and incognito-based consumer browsing; by our estimates, only 35% of real-time ad impressions...

Bigben                                                        Press release Lesquin,17 June 2022, 18:00hrs Distribution in kind of Nacon shares BIGBEN INTERACTIVE (“BBI” or the “Company”) informs its shareholders of the technical details of the exceptional distribution in kind of NACON shares (“Nacon”). The Board of Directors of BBI will propose to its shareholders, at the annual general meeting convened for 22 July 2022 (the “General Meeting”), to approve – in addition to a standard distribution of a cash dividend of EUR 0.30 per share – a distribution in kind in the form of Nacon shares at the rate of one (1) Nacon share for every four (4) BBI shares held, the terms and conditions of which are described below. This distribution in kind of Nacon shares will be paid on 29 July 2022. The...

                                                                 Bollène, June 17, 2022 – 06:00 pm (CET) Press ReleaseFor immediate release BANC OF CALIFORNIA SIGNS THE EXTENSION TO SEPTEMBER 30, 2022 Egide Group announces the closing with Banc of California of the amendments to the loan agreements allowing to support the credit lines of the two American entities (Egide USA and Santier) until 30 September 2022. In addition, Egide Group will soon inform the market on the conclusion of the negotiations still in progress for the two cumulative financing projects at Egide USA and Santier. Next Financial Information : 2022 H1 revenue:                 July 21, 2022 About Egide – www.egide-group.com Egide is a group with an international dimension. specialized in the manufacture of hermetic packages and heat dissipation solutions for sensitive...

Habitat for Humanity 2022 Elected officials and community leaders joined representatives from Newport News Shipbuilding and Habitat for Humanity Peninsula and Greater Williamsburg Thursday to welcome the Hunter family to their new home. The house is the 19th that shipyard volunteers have constructed in partnership with Habitat for Humanity.NEWPORT NEWS, Va., June 17, 2022 (GLOBE NEWSWIRE) — Global defense and technologies partner HII (NYSE: HII) announced today that the company’s Newport News Shipbuilding division joined elected officials and community leaders Thursday to dedicate the 19th house shipyard volunteers have constructed in partnership with Habitat for Humanity Peninsula and Greater Williamsburg since 2002. The ribbon-cutting welcomed Mickeia Hunter and her children — Cinque and Nehemiah — to their new home. Julia...

NASHVILLE, TN, June 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – LIG Assets, Inc. announced that to facilitate the addition of new executives to our leadership team and board of directors, Ms. Dakota Forgione has decided to depart as CEO and board member of the company. During her tenure at LIGA her most active role was as an internal investment banker, and she will continue to assist in these functions moving forward.  Ms. Forgione was successful in helping in the sale of the Brentwood property, as well as the resolution of the IRS lien that was converted from a $1.5 million assessment into a $3.1 million tax loss carried forward for LIG Assets. “I have informed the board that I have decided to leave LIG Assets, Inc. but plan on helping the company from a consulting position. LIGA is in position to move forward with the restructure...

ANAHEIM, CA, June 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Tom Welch, Executive Vice President of BioCorRx Inc., was featured on LiveNOW from FOX. Mr. Welch discussed BioCorRx’s pilot program with 2B3D, a virtual, augmented, and mixed reality technology company, a first-of-its-kind post-traumatic stress disorder (PTSD) and addiction treatment solutions program for veterans in the metaverse setting. LiveNOW from FOX is a non-stop stream of breaking news, live events and stories taking place across the nation. To watch the interview, please go to: https://www.biocorrx.com/news-media/media. About BioCorRx BioCorRx Inc. (OTCQB: BICX) is an addiction treatment solutions...

First demonstration of the survival of allogeneic islet cells, cardiomyocytes, and retinal pigment epithelium cells transplanted into an immunocompetent non-human primate model without any immune suppression The islet autoimmune data suggest that cells with hypoimmune (HIP) edits evade allogeneic immune response and autoimmune response in a type 1 diabetes mouse model Transplanting allogeneic cells into a non-human primate without immune suppression represents a key step toward development of engineered cells for the treatment of disease SEATTLE, June 17, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, presented data showing survival of transplanted allogeneic, hypoimmune cells of several different types in a variety of locations in non-human...

Results to be Presented in Late-Breaking Session SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, today announced that the Company will present one-year, safety and efficacy results from its HOPE-2 open-label extension study with lead asset CAP-1002 for treating Duchenne muscular dystrophy (DMD) at this year’s Parent Project Muscular Dystrophy (PPMD) Annual Conference. The details are as follows:Dr. Linda Marbán, CEO, will present the one-year open label extension results via a late-breaking session on June 25, 2022, at 5:05 p.m. MT. Capricor will also deliver a clinical update as part of PPMD’s “Novel Approaches for Combatting...